Class III — Low Risk

Low risk — use of or exposure to this product is not likely to cause adverse health consequences.

CytoScan¿ Dx Assay. The CytoScan Dx Assay consists of five reagent modules Recalled by Affymetrix Inc Due to During a recent Ohio site inspection by the...

Date: April 14, 2016
Company: Affymetrix Inc
Status: Terminated
Source: FDA (Device)

What You Should Do

Stop using this product immediately. Do not consume, use, or distribute it.

Return the product to the place of purchase for a full refund. If you have questions, contact Affymetrix Inc directly.

Affected Products

CytoScan¿ Dx Assay. The CytoScan Dx Assay consists of five reagent modules, wash buffers (WS), a microarray kit, and analysis software. The CytoScan Dx Assay consists of five reagent modules, wash buffers (WS), a microarray kit, and analysis software: MOD R LA, CytoScan¿ Dx Pre-PCR (-20¿C) MOD T E W, CytoScan¿ Dx Pre-PCR (2¿-8¿C) MOD F L H, CytoScan¿ Dx Post-PCR (-20¿C) MOD S AH W PB, CytoScan¿ Dx Post-PCR (2¿-8¿C) MOD E PW, CytoScan¿ Dx Post-PCR (15¿- 30¿ C) CytoScan Dx WS A CytoScan Dx WS B CytoScan¿ Dx Array kit, 6Pk ChAS Dx Analysis Software and Browser

Quantity: 507 kits

Why Was This Recalled?

During a recent Ohio site inspection by the FDA it was discovered that warning statements needed to be included with the product shipment.

Where Was This Sold?

This product was distributed to 15 states: AR, CA, MA, MI, MN, NM, NY, NC, PA, SC, TN, TX, WA, WV, DC

Affected (15 states)Not affected

About Affymetrix Inc

Affymetrix Inc has 1 total recall tracked by RecallDetector.

Related Recalls

Data sourced from the FDA (Device). Last updated March 26, 2026. View original report